Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03716440 · ClinicalTrials.gov registry record · NA
Effects of Nature Exposure on Smoking Behavior
A NA study of Tobacco Smoking, sponsored by University of Montana.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT03716440: Completed NA study of Tobacco Smoking, sponsored by University of Montana.
NCT03716440 is a NA study of Tobacco Smoking that has completed, run by University of Montana. The registered enrollment target is 42 participants, below the 476-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03716440, a NA study of Tobacco Smoking, has completed, sponsored by University of Montana.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Smoking continues to be the leading cause of preventable death and disease in the U.S. While smoking is a significant threat to public health in the US in general, the negative effects of smoking disproportionately affect Americans with 12 or fewer years of education and those living below the poverty line. Given these health disparities, it is vital to have widely-available treatments that can be applied in multiple contexts in a cost-efficient way. While numerous methodologies and intervention programs exist, there is a need for improved cessation programs targeted to smokers with low levels of education attainment and income, as these smokers tend to be less likely to receive cessation assistance from a health care provider or have sufficient resources to access treatments. Therefore, the present proposal aims to assess the feasibility of a tool that will improve smoking cessation programs in a short and cost-effective manner: a brief exposure to nature. The health and wellbeing benefits of nature exposure have been well researched and are widely recognized, and research on the underlying mechanism for nature's positive impact on health has identified a reduction in impulsivity as a mediator of this effect. However, this work has never been directly translated to smoking outcomes, and thus the translational purpose of the present project is to assess the feasibility of a brief and cost-effective nature exposure intervention on smoking cessation outcomes. Prior work demonstrates the validity of the causal links in the nature -\> impulsivity -\> smoking cessation model. Research has shown that nature exposure reduces impulsivity for health-related outcomes, and found that increased impulsivity is linked to all stages of smoking. A necessary step in developing a practical application for this research is the aim of the present project. Smokers will be recruited online and randomly assigned to either the Nature or Control condition. Participants in the Nature condi
Primary Outcome
Self reported rating of desire to smoke. This item is scored 1 - 10 (1 = no desire to smoke; 10 = craving to smoke is extreme).
Conditions Studied
Interventions
- OTHER Nature exposure
- OTHER Non-nature exposure
Study Locations (1)
Montana
- University of Montana - Missoula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT03716440 record still lists
NCT03716440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 476-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Tobacco Smoking appearing as the primary indexed condition, and to 2 interventions - of which Nature exposure is the first listed.
NCT03716440 reports a single indexed study location in Montana.
Frequently Asked Questions
What is clinical trial NCT03716440 about?
NCT03716440 is a clinical study titled "Effects of Nature Exposure on Smoking Behavior". Smoking continues to be the leading cause of preventable death and disease in the U.S. While smoking is a significant threat to public health in the US in general, the negative effects of smoking disproportionately affect Americans with 12 or fewer years of education and those living below the pover...
What is the current status of trial NCT03716440?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-04-02. Estimated completion is 2018-06-30.
What conditions does trial NCT03716440 study?
This clinical trial studies the following conditions: Tobacco Smoking.
What interventions are being tested in trial NCT03716440?
The interventions under investigation include: Nature exposure (OTHER), Non-nature exposure (OTHER).
Who is sponsoring clinical trial NCT03716440?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03716440 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03716440's enrollment target sits among peer trials
42 27th of 38 higher than 11 of 38 other Tobacco Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI